Thank you for joining us for BioNJ’s Twelfth Annual BioPartnering Conference, co-sponsored by J.P. Morgan and Johnson & Johnson Innovation. Attendees enjoyed interactive plenary sessions, 1:1 partnering, Company and Pitch presentations, networking and more. Presenting companies ranged from early start-ups to later stage companies and everything in between.

BioNJ’s BioPartnering Conference is designed to foster productive partnerships, create fruitful opportunities, grow the ecosystem and bolster medical innovation. There was a place for all company stages.

At BioNJ, we are committed to the health and safety of our community, therefore plenary sessions, company presentations and 1:1 partnering were held virtually. However, we were excited to offer attendees the opportunity to meet safely for an In-Person Networking Reception on Monday, May 9, from 4:00 – 7:00 p.m. ET; where attendees enjoyed networking, cocktails as well as staff-served “buffet-style” hors d’oeuvres and dinner fare. (Proof of vaccination required to attend the Reception.) The next two days, Tuesday, May 10, and Wednesday, May 11, were held virtually, inclusive of plenary sessions, company presentations, 1:1 partnering and more!